We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Goodwin Biotechnology was Selected by Panacea Pharmaceuticals

News   May 28, 2015

 
Goodwin Biotechnology was Selected by Panacea Pharmaceuticals
 
 
 

RELATED ARTICLES

Gene Therapy Restores Immunity in Infants With Rare Immunodeficiency Disease

News

A small clinical trial has shown that gene therapy can safely correct the immune systems of infants newly diagnosed with a rare, life-threatening inherited disorder in which infection-fighting immune cells do not develop or function normally.

READ MORE

Pneumococcal Vaccine Has Big Impact Even for the Unvaccinated

News

A vaccine against Streptococcus pneumoniae, a major cause of childhood illness and mortality in the developing world, sharply reduced the incidence of serious pneumococcal disease among children in a large Kenyan community.

READ MORE

A New Way to Build Novel Synthetic Biomolecules

News

Army scientists have discovered how to build novel synthetic biomolecule complexes that they believe are a critical step towards biotemplated advanced materials.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE